Huons Meditech offers a new paradigm for ESWT in urology

[Shin-Min Joon, Edaily Reporter] Huons Meditech of Huons Group offers a new paradigm for extracorporeal shock wave therapy (ESWT) in urology.

Huons Meditech held a ‘CP&CPPS Treatment Symposium’ at Seoul Dragon City Hotel to showcase IMPO88 Plus competitiveness. (Image=Huons Meditech)

Huons Meditech announced on June 30 that it successfully held Chronic Prostatitis&Chronic Pelvic Pain Syndrome Treatment Symposium (CP&CPPS Treatment Symposium) on June 28 at Seoul Dragon City Hotel.

Huons Meditech, which holds the largest domestic ESWL (Extracorporeal Shock Wave Lithotriptor) market share, gathered local urologists to showcase and share clinical cases of its newest ESWT device ‘IMPO88 Plus’. IMPO88 Plus is the next generation of IMPO88, the ESWT device designed for Erectile Dysfunction (ED) treatment and chronic pain management.

Meanwhile, ESWT devices were generally used to treat musculoskeletal disorders; however, IMPO88 Plus is known as Korea’s first low intensity ESWT, clinically proven to have effect on relieving symptoms of ED and CP&CPPS.

Professor Hong Sung Kyu (Department of Urology at Seoul National University Bundang Hospital) chaired the symposium, while Professor Park Heung Jae (Department of Urology at Kangbuk Samsung Hospital) presented clinical cases of IMPO88 Plus for ED. Certified Director Han Byoung Kyu (Urological Endoscopy Certification Committee at The Korean Urological Association) shared his knowledge on disinfection of urological endoscopes.

Professor Shin Dongho (Department of Urology at Seoul St. Mary‘s Hospital) who led the clinical study attracted much attention when he presented the efficacy and safety of ESWT on CP&CPPS.

Professor Shin Dongho said “IMPO88 Plus is the only ESWT device in Korea that has proven effect on inflammatory and non-inflammatory CPPS. This device provides a new treatment option which can reduce or even replace antibiotic prescriptions for CP&CPPS patients.”

CEO of Huons Meditech Lee Jin suk said “Following the CP&CPPS Treatment Symposium, I expect that IMPO88 Plus will lead a paradigm shift of ESWT treatment in urology. Huons Meditech will continue to develop innovative medical devices that can be used in various fields such as in gynecology and dermatology.

Huons Meditech continues to put efforts in process standardization and training programs to foster skilled manufacturing workers in order to manufacture high quality medical devices. The company has a dedicated aftersales quality control organization and operates an advanced system for same day response and immediate action in response to customer complaints.

신민준 (adonis@edaily.co.kr)